Reconstitution of norovirus-specific T cell responses following hematopoietic stem cell transplantation in patients with inborn errors of immunity and chronic norovirus infection.

Autor: Durkee-Shock J; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Cohen A; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA., Maghzian N; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA., Pezzella G; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA., Jensen-Wachspress M; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA., Hostal A; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Barton K; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Gangler K; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Dávila Saldaña BJ; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC, USA., Chaimongkol N; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Bollard CM; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC, USA., Sosnovtsev SV; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Cohen J; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Nagata BM; Infectious Disease Pathogenesis Section, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA., Alves DA; Infectious Disease Pathogenesis Section, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA., Ghosh R; NIAID Centralized Sequencing Program, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Seifert BA; NIAID Centralized Sequencing Program, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Freeman A; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Gonzalez C; Immune Deficiency Cellular Therapy Program, National Cancer Institute, Bethesda, MD, USA., Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Green KY; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Keller MD; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.; Division of Allergy and Immunology, Children's National Hospital, Washington DC, USA.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.

Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease.

Autor: Kinoshita H; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC., Mandava M; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC., Jensen-Wachspress M; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC., Lang H; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC., Joy E; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC., Tanna J; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC., McCann CD; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC., O'Brien S; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC., Burnett S; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC., Shibli A; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC., Hoq F; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC., Bhatia M; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY., Hanley PJ; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC.; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC.; GW Cancer Center, George Washington University School of Medicine and Health Sciences, Washington, DC., Dávila Saldaña B; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC.; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC.; GW Cancer Center, George Washington University School of Medicine and Health Sciences, Washington, DC., Mahadeo KM; Department of Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX., Bollard CM; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC.; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC.; GW Cancer Center, George Washington University School of Medicine and Health Sciences, Washington, DC., Keller MD; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC.; GW Cancer Center, George Washington University School of Medicine and Health Sciences, Washington, DC., Abraham A; Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC.; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC.; Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC.; GW Cancer Center, George Washington University School of Medicine and Health Sciences, Washington, DC.

Publikováno v: Blood advances [Blood Adv] 2023 May 23; Vol. 7 (10), pp. 2105-2116.

Spike-directed vaccination elicits robust spike-specific T-cell response, including to mutant strains.

Autor: Stanojevic M; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA., Geiger A; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA., Ostermeier B; Institute for Biomedical Sciences, George Washington University, Washington, DC, USA., Sohai D; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA., Lazarski C; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA., Lang H; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA., Jensen-Wachspress M; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA., Webber K; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA., Burbelo P; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA., Cohen J; National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA., Keller MD; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA., Bollard CM; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA. Electronic address: cbollard@childrensnational.org., Cruz CRY; Program for Cell Enhancement and Technologies for Immunotherapy, Children's National Medical Center, Washington, DC, USA. Electronic address: ccruz@childrensnational.org.

Publikováno v: Cytotherapy [Cytotherapy] 2022 Jan; Vol. 24 (1), pp. 10-15. Date of Electronic Publication: 2021 Sep 02.

A T cell receptor specific for an HLA-A*03:01-restricted epitope in the endogenous retrovirus ERV-K-Env exhibits limited recognition of its cognate epitope.

Autor: Grundy, Erin E.^1,2,3 (AUTHOR), Shaw, Lauren C.⁴ (AUTHOR), Wang, Loretta^1,2 (AUTHOR), Lee, Abigail V.^1,2,3 (AUTHOR), Argueta, James Castro⁵ (AUTHOR), Powell Jr, Daniel J.⁴ (AUTHOR), Ostrowski, Mario⁶ (AUTHOR), Jones, R. Brad⁷ (AUTHOR), Cruz, C. Russell Y.^2,3,8 (AUTHOR), Gordish-Dressman, Heather^5,9 (AUTHOR), Chappell, Nicole P.² (AUTHOR), Bollard, Catherine M.^2,3,8 (AUTHOR), Chiappinelli, Katherine B.^1,2,3 (AUTHOR) kchiapp1@email.gwu.edu

Publikováno v: Mobile DNA. 10/9/2024, Vol. 15 Issue 1, p1-18. 18p.

Genomic Landscape of Susceptibility to Severe COVID-19 in the Slovenian Population †.

Autor: Kovanda, Anja^1,2 (AUTHOR) anja.kovanda@kclj.si, Lukežič, Tadeja¹ (AUTHOR), Maver, Aleš^1,2 (AUTHOR), Vokač Križaj, Hana¹ (AUTHOR), Čižek Sajko, Mojca¹ (AUTHOR), Šelb, Julij³ (AUTHOR), Rijavec, Matija³ (AUTHOR), Bidovec-Stojković, Urška³ (AUTHOR), Bitežnik, Barbara³ (AUTHOR), Rituper, Boštjan³ (AUTHOR), Korošec, Peter³ (AUTHOR), Peterlin, Borut^1,2 (AUTHOR) anja.kovanda@kclj.si

Publikováno v: International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 14, p7674. 16p.